MetLife Investment Management’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$170K Buy
15,288
+6,083
+66% +$67.8K ﹤0.01% 2272
2025
Q1
$113K Hold
9,205
﹤0.01% 2471
2024
Q4
$103K Buy
+9,205
New +$103K ﹤0.01% 2610